Skip to main content

Table 1 Demographic baseline population characteristics and IScore variables at 30-days and 1-year

From: Evaluation of IScore validity in a Greek cohort of patients with type 2 diabetes

Variable

Entire population

Diabetic patients (n=312)

Non diabetic patients (n=222)

p-value

iScore 30 days

166,1 ± 56,3

185,3 ± 45,9

139,1 ± 58,7

<0,05#

iScore 1 year

136,3 ± 41

149,1 ± 22,6

118,3 ± 43,6

<0,05#

Age (mean±SD)

74,7 ± 6,6

75.03 ± 6.6

74.22 ± 6.5

0,222##

74 (69 - 82)

74 (69 - 80)

Gender n (%)

0,628*

Female

276

158 (50.6)

118 (53.2)

Male

258

154 (49.4)

104 (46.8)

Stroke severity (CNS) n (%)

0,247*

0

21

13 (4.2)

7 (3.2)

≤4

75

36 (11.5)

39 (17.6)

5-7

204

123 (39.4)

81 (36.5)

≥8

235

140 (44.9)

95 (42.8)

Stroke subtype n (%)

<0,05*

Lacunar origin

244

168 (53.8)

76 (34.2)

Nonlacunar origin

219

102 (32.7)

117 (52.7)

Undetermined origin

71

42 (13.5)

29 (13.1)

Risk factor n (%)

0,304*

Atrial fibrillation

80

46 (14.7)

34 (15.3)

CHF

67

44 (14.1)

23 (10.4)

Previous MI

148

99 (31.7)

49 (22.1)

Current smoker

100

57 (18.3)

43 (19.4)

Comorbid condition n (%)

0,809**

Cancer

53

34 (10.9)

19 (8.6)

Renal dialysis

9

5 (1.6)

4 (1.8)

Preadmission disability n (%)

0,532*

Independent

435

254 (81.4)

181 (81.5)

Dependent n

99

58 (18.6)

41 (18.5)

Glucose on admission, mmol/L,dL n (%)

<0,05*

<7.5 (<135)

295

159 (51)

136 (61.3)

≥7.5 (≥135)

239

153 (49)

86 (38.7)

Mortality rate n (%)

0,551*

30 Day

77

45 (14.4)

32 (14.4)

1 Year

141

86 (27.6)

55 (24.8)

0,268*

  1. SD indicates standard deviation; CNS: Canadian neurological scale; CHF: congestive heart failure; MI: myocardial infarction.
  2. Statistical methods used: #Mann Whitney U test, ##t-Test, *Chi-square, **Fisher.